The following tables present the Company’s fair value hierarchy for those assets and liabilities measured at fair value (in millions):


	Fair Value Measurements Using:
	Total as of March 31, 2026		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other current assets
Derivatives	$	115	$	—	$	115	$	—




Other noncurrent assets

Deferred compensation plan assets	63		63		—		—
Exchange traded funds (fixed income)(1)	71		71		—		—
Exchange traded funds (equity)(1)	205		205		—		—



Total assets	$	454	$	339	$	115	$	—
Other current liabilities
Derivatives	$	136	$	—	$	136	$	—

Contingent earn-out liabilities	14		—		—		14


Total liabilities	$	150	$	—	$	136	$	14

(1) Classified as restricted investments for payment of asbestos liabilities. See Note 18, "Commitments and Contingencies," of the notes to the consolidated financial statements for further details.


	Fair Value Measurements Using:
	Total as of September 30, 2025		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Other current assets
Derivatives	$	15	$	—	$	15	$	—



Other noncurrent assets


Deferred compensation plan assets	63		63		—		—
Exchange traded funds (fixed income)(1)	73		73		—		—
Exchange traded funds (equity)(1)	217		217		—		—



Total assets	$	368	$	353	$	15	$	—
Other current liabilities
Derivatives	$	24	$	—	$	24	$	—
Contingent earn-out liabilities	19		—		—		19


Total liabilities	$	43	$	—	$	24	$	19

(1) Classified as restricted investments for payment of asbestos liabilities. See Note 18, "Commitments and Contingencies," of the notes to the consolidated financial statements for further details.